Overexpression of SLC7A7 predicts poor progression-free and overall survival in patients with glioblastoma

Fan, Songhua; Meng, Delong; Xu, Tao; Chen, Yuanyuan; Wang, Jingkun; Li, Xiaoying; Chen, Hongyan; Lu, Daru; Chen, Juxiang; Lan, Qing
March 2013
Medical Oncology;Mar2013, Vol. 30 Issue 1, p1
Academic Journal
The clinical significance of SLC7A7 expression remains unclear. In this study, we aimed to explore whether SLC7A7 expression in tumor tissues could be used to assess subsequent prognosis in patients with glioblastoma (GBM). A total of 119 patients with pathologically confirmed GBM and 16 normal controls were recruited for this study. The expression of SLC7A7 in GBM and normal tissues was evaluated by immunohistochemistry in tissue microarrays and quantitative real-time PCR. Kaplan-Meier method and Cox's proportional hazards model were used in survival analysis. Compared with normal tissues, GBM specimens had significantly increased expression of SLC7A7 at both mRNA and protein levels (both P < 0.05). Moreover, multivariate analysis confirmed that overexpression of SLC7A7 was a significant and independent indicator for predicting poor prognosis. Our results suggest, for the first time, that overexpression of SLC7A7 is correlated with worse outcomes in patients with GBM. SLC7A7 plays a critical role in GBM carcinogenesis and may be a potential prognosis predictor of GBM.


Related Articles

  • Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients. Sana, Jiri; Radova, Lenka; Lakomy, Radek; Kren, Leos; Fadrus, Pavel; Smrcka, Martin; Besse, Andrej; Nekvindova, Jana; Hermanova, Marketa; Jancalek, Radim; Svoboda, Marek; Hajduch, Marian; Slampa, Pavel; Vyzula, Rostislav; Slaby, Ondrej // Carcinogenesis;Dec2014, Vol. 35 Issue 12, p2756 

    We described miRNA expression profile of GBM tissue and developed Risk Score algorithm based on six-miRNA signature associated with GBM patients survival. This Risk Score indicated superiority in prediction of clinical outcome when compared with commonly used MGMT methylation status.Glioblastoma...

  • Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis. Wang, Xingfu; Chen, Yupeng; Zhang, Sheng; Zhang, Lifeng; Liu, Xueyong; Zhang, Li; Li, Xiaoling; Chen, Dayang // Journal of Neuro-Oncology;Nov2015, Vol. 125 Issue 2, p277 

    Cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LO) are important factors in tumorigenesis and malignant progression; however, studies of their roles in glioblastoma have produced conflicting results. To define the frequencies of COX-2 and 5-LO expression and their correlation with...

  • Gene Expression Profile of Glioblastoma Multiforme Invasive Phenotype Points to New Therapeutic Targets. Hoelzinger, Dominique B.; Mariani, Luigi; Weis, Joachim; Woyke, Tanja; Berens, Theresa J.; McDonough, Wendy S.; Sloan, Andrew; Coons, Stephen W.; Berens, Michael E. // Neoplasia;Jan2005, Vol. 7 Issue 1, p7 

    The invasive phenotype of glioblastoma multiforme (GBM) is a hallmark of malignant process, yet molecular mechanisms that dictate this locally invasive behavior remain poorly understood. Gene expression profiles of human glioma cells were assessed from laser capture-microdissected GBM cells...

  • Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric Astrocytomas. Engler, Jane R.; Robinson, Aaron E.; Smirnov, Ivan; Hodgson, J. Graeme; Berger, Mitchel S.; Gupta, Nalin; James, C. David; Molinaro, Annette; Phillips, Joanna J.; Jones, Chris // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    Glioblastoma (GBM) is a highly malignant brain tumor with a dismal prognosis. Gene expression profiling of GBM has revealed clinically relevant tumor subtypes, and this provides exciting opportunities to better understand disease pathogenesis. Results from an increasing number of studies...

  • Glioblastoma multiforme with long term survival. Deb, Prabal; Sharma, Mehar Chand; Mahapatra, Ashok Kumar; Agarwal, Deepak; Sarkar, Chitra // Neurology India;Sep2005, Vol. 53 Issue 3, p329 

    Glioblastoma multiforme (GBM) Patients generally have a dismal prognosis, with median survival of 10-12 months. GBM with long-term survival (LTS) of ≥ 5 years is rare, and no definite markers indicating better prognosis have been identified till date. The present study was undertaken to...

  • Identification of miRNA-Mediated Core Gene Module for Glioma Patient Prediction by Integrating High-Throughput miRNA, mRNA Expression and Pathway Structure. Zhang, Chunlong; Li, Chunquan; Li, Jing; Han, Junwei; Shang, Desi; Zhang, Yunpeng; Zhang, Wei; Yao, Qianlan; Han, Lei; Xu, Yanjun; Yan, Wei; Bao, Zhaoshi; You, Gan; Jiang, Tao; Kang, Chunsheng; Li, Xia // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    The prognosis of glioma patients is usually poor, especially in patients with glioblastoma (World Health Organization (WHO) grade IV). The regulatory functions of microRNA (miRNA) on genes have important implications in glioma cell survival. However, there are not many studies that have...

  • Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas.  // Journal of Experimental & Clinical Cancer Research (17569966);2011, Vol. 30 Issue 1, p76 

    The article presents a study which examines the downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas. It mentions malignant gliomas are the most common in central nervous system cancer and identifies CDKN2A as a susceptibility loci for glioma. It...

  • The Clinical and Prognostic Significance of Activated AKT-mTOR Pathway in Human Astrocytomas. Habr, Elias A. El; Adamopoulos, Christos; Levidou, Georgia; Saetta, Aggeliki A.; Korkolopoulou, Penelope; Piperi, Christina // Neurology Research International;2012, p1 

    Astrocytomas, the most common type of gliomas, and especially grade IV glioblastomas are "endowed" with strong proliferation and invasion potentials, high recurrence rate, and poor patients' prognosis. Aberrant signaling of AKT-mTOR (mammalian target of rapamycin) has been implicated in...

  • Changes in the expression of proteins associated with aerobic glycolysis and cell migration are involved in tumorigenic ability of two glioma cell lines. RamÆo, Anelisa; Gimenez, Marcela; Laure, Helen Julie; Izumi, Clarice; Vida, Rodrigo Cesar dos Santos; Oba-Shinjo, Sueli; Marie, Suely Kazue Nagahashi; Rosa, Jose Cesar // Proteome Science;2012, Vol. 10 Issue 1, p53 

    Background: The most frequent and malignant brain cancer is glioblastoma multiforme (GBM). In gliomas, tumor progression and poor prognosis are associated with the tumorigenic ability of the cells. U87MG cells (wild-type p53) are known to be tumorigenic in nude mice, but T98G cells (mutant p53)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics